Search
Search Funnelback University
- Refined by:
- Date: 2022
Your query has been expanded to `news stories` |u:www.enterprize.cam.ac.uk. Search for `news stories` |u:www.enterprise.cam.ac.uk instead.
81 -
100 of
178
search results for `news stories` |u:www.enterprise.cam.ac.uk or `news stories` |u:www.enterprize.cam.ac.uk
Fully-matching results
-
Human CD235a monoclonal antibody YTH 89.1
https://www.enterprise.cam.ac.uk/reagents/human-cd235a-monoclonal-antibody-yth-89-1/9 May 2022: Hybridoma cell line producing YTH 89.1 antibodies raised against human CD235a which are rat monoclonal antibodies of the IgG2b isotype.
-
Cambridge recognised for its leadership in knowledge exchange –…
https://www.enterprise.cam.ac.uk/news/cambridge-recognised-for-its-leadership-in-knowledge-exchange/27 Sep 2022: Cambridge’s leadership in knowledge exchange has been recognised in today's Knowledge Exchange Framework 2 (KEF2) results, published by Research England.
-
Brief Early Skills & Support Index (BESSI) – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/reagents/brief-early-skills-support-index-bessi/9 May 2022: Questionnaire developed at the University of Cambridge and validated for use with reception- and nursery-aged children.
-
Consultancy services case study – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/consultancy-services-a-university-lab-tests-anti-viral-materials-for-companies/11 Apr 2022: Our consultancy services team supported Department of Chemical Engineering and Biotechnology researchers in testing anti-viral materials.
-
FcgRlla 131R receptor expressing cell line
https://www.enterprise.cam.ac.uk/reagents/fcgrlla-131r-receptor-expressing-cell-line/9 May 2022: CHO cells transfected to express human FcgRlla allotype 131R as a transmembrane protein with its native intracellular domain.
-
Cambridge spin-out raises £4.2m to tackle gigatonnes of emissions…
https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-raises-4-2m-to-tackle-gigatonnes-of-emissions-from-highly-pollutive-cement-industry/8 Nov 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 7 November 2022. Cambridge spin-out raises £4.2m to tackle gigatonnes of emissions from highly pollutive cement industry. Share:. University of Cambridge and UCL joint spin-out to
-
FcgRlla 131H receptor expressing cell line
https://www.enterprise.cam.ac.uk/reagents/fcgrlla-131h-receptor-expressing-cell-line/9 May 2022: CHO cells transfected to express human FcgRlla allotype 131H as a transmembrane protein with its native intracellular domain.
-
3C Programme: Supporting the development of innovation ecosystems in…
https://www.enterprise.cam.ac.uk/case-studies/3c-programme-supporting-the-development-of-innovation-ecosystems-in-argentina/11 Apr 2022: Cambridge Enterprise is collaborating with 3C Programme, an international consortium supporting the development of technology innovation ecosystems in Argentina.
-
Human CD66acd monoclonal antibody YTH 71.3
https://www.enterprise.cam.ac.uk/reagents/human-cd66acd-monoclonal-antibody-yth-71-3/9 May 2022: Hybridoma cell line producing YTH 71.3 antibodies raised against human CD66acd which are rat monoclonal antibodies of the IgG2a isotype.
-
Centessa Pharmaceuticals – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/centessa-pharmaceuticals-three-portfolio-companies-merge-into-a-new-pharmaceutical-giant/11 Apr 2022: Centessa Pharmaceuticals, which launched with $250 million in Series A financing, acquired three Cambridge Enterprise portfolio companies.
-
Cambridge spin-out raises $6m seed round for transformative…
https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-raises-6m-seed-round-for-transformative-regulatory-data-structures/12 Apr 2022: University of Cambridge spin-out RegGenome announces the completion of a $6 million seed funding round.
-
FcgRllb 131R receptor expressing cell line
https://www.enterprise.cam.ac.uk/reagents/fcgrllb-131r-receptor-expressing-cell-line/9 May 2022: CHO cells transfected to express human FcgRllb allotype 131R as a transmembrane protein with its native intracellular domain.
-
Human CD45R monoclonal antibody YTH 80.103
https://www.enterprise.cam.ac.uk/reagents/human-cd45r-monoclonal-antibody-yth-80-103/9 May 2022: Hybridoma cell line producing YTH 80.103 antibodies raised against human CD45R which are rat monoclonal antibodies of the IgG2b isotype.
-
Versed AI case study – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/versed-ai-harnessing-artificial-intelligence-to-reveal-hidden-supply-chain-risks/11 Apr 2022: Mining millions of words in news articles, business reports, and social media posts, Versed AI’s technology maps out multi-tier supply chains, revealing patterns and shining light on missing links.
-
Innovate Cambridge initiative to support, promote and enhance the…
https://www.enterprise.cam.ac.uk/news/astrazeneca-and-microsoft-join-steering-committee-as-innovate-cambridge-initiative-to-support-promote-and-enhance-the-cambridge-innovation-ecosystem-on-the-global-stage-gains-momentum/8 Dec 2022: Today’s news, last night’s event, and the subsequent number of signatures we have secured for the charter to date, have confirmed that we are securing visible commitment from all
-
Human CD25 monoclonal antibody YTH 906.9HL
https://www.enterprise.cam.ac.uk/reagents/human-cd25-monoclonal-antibody-yth-906-9hl/9 May 2022: Hybridoma cell line producing YTH 906.9HL antibodies raised against human CD25 which are rat monoclonal antibodies of the IgG2b isotype.
-
Mouse CD45 monoclonal antibody YW 62.3.20
https://www.enterprise.cam.ac.uk/reagents/mouse-cd45-monoclonal-antibody-yw-62-3-20/9 May 2022: Hybridoma cell line producing YW 62.3.20 antibodies raised against mouse CD45 which are rat monoclonal antibodies of the IgG2b isotype.
-
Cambridge spin-out enters $42m partnership to develop…
https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-enters-42m-partnership-to-develop-future-proofed-coronavirus-vaccines/8 Mar 2022: Cambridge spin-out DIOSynVax will receive $42 million to develop a vaccine candidate to protect against existing and future variants of SARS-CoV-2.
-
Mouse CD71 monoclonal antibody YTA 74.4.4
https://www.enterprise.cam.ac.uk/reagents/mouse-cd71-monoclonal-antibody-yta-74-4-4/9 May 2022: Hybridoma cell line producing YTA 74.4.4 antibodies raised against mouse CD71 which are monoclonal antibodies of the IgG2a isotype.
-
BKwai raises £2.2m seed round – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/cambridge-joins-2-2m-seed-round-for-data-driven-infrastructure-and-construction-platform/8 Mar 2022: Cambridge Enterprise joins £2.2 million seed round for construction data company BKwai, helping develop smarter, more sustainable infrastructure.
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.